FDA NDC Directory · JSON-LD · Markdown

Cephalexin

NDC 68071-2889 · HUMAN PRESCRIPTION DRUG · FOR SUSPENSION

Labeler / ManufacturerNuCare Pharmaceuticals,Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA210221
Dosage form / routeFOR SUSPENSION · ORAL
Active ingredientsCEPHALEXIN (250 mg/5mL)
Marketing started20190328
Package count1

External sources

Source: openFDA. Public-domain (CC0).